Jackie Schumacher
About Jackie Schumacher
Jackie Schumacher Career Overview
Jackie Schumacher has accumulated over 35 years of experience in global regulatory affairs, development, commercialization, and portfolio management. Her career spans from initial clinical investigations through the registration process. This extensive background highlights her expertise in regulatory frameworks, product development, and portfolio oversight.
Jackie Schumacher Role at Lyndra Therapeutics
At Lyndra Therapeutics, Jackie Schumacher served as the Vice President of Regulatory and Quality. In this capacity, she was responsible for devising regulatory and quality strategies, ensuring that the company’s products met all necessary standards and regulations. Her leadership was critical in steering the organization through complex regulatory landscapes.
Jackie Schumacher Tenure at Pfizer
Jackie Schumacher spent over two decades at Pfizer, where she significantly contributed to pharmaceutical sciences. She held regulatory leadership positions within Pfizer's former Established Products Sterile Injectables organization. Jackie developed and led successful global CMC registration strategies for new small molecules, product enhancements, and combination products. Her work played a key role in Pfizer's regulatory accomplishments.
Jackie Schumacher Board Memberships and Advocacy
Jackie Schumacher represents Rallybio on the Board of Directors for BIOCT and the Soderstrom Scholars Fund, where she also chairs the mentoring committee. Additionally, she is engaged with the BIO Rare Disease and Orphan Drug Specialty Committee, providing a platform to discuss major advocacy issues and policies concerning the development and marketing of orphan drug products. Her involvement demonstrates her commitment to advancing pharmaceutical education and policy.
Jackie Schumacher Educational Background
Jackie Schumacher received her Bachelor of Arts in chemistry and classical studies from Hamilton College. This educational foundation laid the groundwork for her extensive career in pharmaceutical sciences and regulatory affairs.